(PWRME, MEMS, BTFG, HDSN, ORFG) Hot Stock by Stock-PR.com

<p align="center">Stock-PR Reporting</p>
<p align="center"><a title="Stock-PR website" href="stock-pr.com" target="_blank"><img class="alignnone size-full wp-image-2414" title="stockpr_logo-site" alt="stockpr_logo-site" src="stock-pr.com/img/stockpr_logo-site.jpg" /></a></p>
<p align="center"> </p>
<p align="center"><strong><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="pennyomega.com/?page_id=835"></a></strong></p>
<p align="center"><strong><span style="COLOR: black">FREE Daily Stock Alerts From Stock-PR.com</span></strong></p>
<p style="TEXT-ALIGN: center"> </p>
<p align="center"><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="stock-pr.com/?page_id=1085"></a></p>
<p align="center"><span style="COLOR: black"><strong><span style="COLOR: black"><strong><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><a title="stock-pr sign up" href="stock-pr.com/signup" target="_blank"><img height="90" alt="chartstockalert" src="pennyomega.com/img/chartstockalert.jpg" width="360" /></a></span></span></strong></span></strong></span></p>
<p align="center"> </p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong><img style="WIDTH: 132px; HEIGHT: 57px" height="63" alt="power3" hspace="0" src="pennyomega.com/img/power3.png" width="152" align="bottom" border="0" mce_src="pennyomega.com/img/power3.png" /> Power3 Medical Products, Inc. (PWRME.OB)<br /></strong><br />
<strong>Power3 Medical Products, Inc.</strong> is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black">Amyotrophic lateral sclerosis (ALS) causes weakness with a wide range of disabilities. Eventually, all muscles under voluntary control are affected, and patients lose their strength and the ability to move their arms, legs, and body. When muscles in the diaphragm and chest wall fail, patients lose the ability to breathe without ventilator support. Most people with Amyotrophic lateral sclerosis die from respiratory failure, usually within 3 to 5 years from the onset of symptoms. However, about 10 percent of Amyotrophic lateral sclerosis patients survive for 10 or more years.</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black">The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black">Please visit Power3 Medical Products, Inc website</font> <a href="www.power3medical.com"><font color="black">www.power3medical.com</font></a><font color="black">.<br />
<br />
*************************************************************************************<br />
<br />
<strong>MEMSIC, Inc. (Nasdaq:MEMS)</strong> announced that it will release financial results for the first quarter of 2011 before the market opens on Tuesday, May 10, 2011. Management will hold a conference call and webcast at 10:00 a.m. EDT that day to review and discuss the company's results.<br />
<br />
MEMSIC, Inc. provides semiconductor sensor systems solutions based on micro electromechanical systems (MEMS) technology and mixed signal circuit design worldwide. MEMSIC, Inc. was founded in 1999 and is headquartered in Andover, Massachusetts.<br />
<br />
**********************************</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong>BancTrust Financial Group, Inc. (Nasdaq:BTFG)</strong> reported its financial results for the quarter ended March 31, 2011. The Company reported that its first quarter 2011 net income, before the preferred dividend, was $1.0 million compared with net income, before the preferred dividend, of $1.1 million in the first quarter of 2010. Net income available to common shareholders was $251,000, or $0.01 per fully diluted share, for the first quarter of 2011 compared with $386,000, or $0.02 per fully diluted share, for the first quarter of 2010. The first quarter net income available to common shareholders was net of a preferred stock dividend of $769,000 in 2011 and $739,000 in 2010.<br />
<br />
BancTrust Financial Group, Inc. operates as the bank holding company for BankTrust, which provides various financial services to individuals, small businesses, and other organizations in southern Alabama and northwest Florida.<br />
<br />
**********************************</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong>Hudson Technologies Inc. (Nasdaq:HDSN)</strong> will host a conference call and webcast on Wednesday, May 4, 2011 at 10:00 a.m. Eastern Time to discuss the Company's first quarter results. To access the live webcast log onto the Hudson Technologies website at</font> <a href="www.hudsontech.com"><font color="black">hudsontech.com</font></a> <font color="black">and click on "Investor Relations". To participate in the call by phone, dial (877) 407-9210 approximately five minutes prior to the scheduled start time. International callers please dial (201) 689-8049. A replay of the webcast will be available until May 11, 2011 and may be accessed by dialing (877) 660-6853 and international callers may dial (201) 612-7415. Callers should use account number 286 and pass code 371890.<br />
<br />
Hudson Technologies, Inc., through its subsidiary, Hudson Technologies Company, provides refrigerant services and solutions in the refrigeration industry primarily in the United States.<br />
<br />
**********************************</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><br />
<br />
<strong><img class="alignnone size-full wp-image-5182" title="orfg_logo203x87" style="WIDTH: 185px; HEIGHT: 79px" height="79" alt="orfg_logo203x87" hspace="0" src="bestotc.com/img/orfgx.png" width="185" align="bottom" border="0" /> Orofino Gold Corp. (ORFG)<br /></strong><br />
Orofino's corporate objective is to continue to build shareholder value through the exploration and development of Senderos de Oro and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.<br />
<br />
Orofino has begun moving aggressively to confirm the current mineralogical interpretations, fast-tracking analysis work with a goal of beginning drilling within the year. La Azul features numerous geological similarities to Greystar's Angostura project and Ventana's La Bodega project, but La Azul is suspected to be of a higher grade and more easily accessible.<br />
<br />
In medicine, gold is used in diagnosis as well as treatment of certain medical conditions. In spacecrafts, gold is used to lubricate various mechanical parts as organic lubricants are hardly of any use in the vacuum of space, where radiation is much more than on Earth.</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong>Orofino Gold Corp</strong>. has several Gold development properties in Colombia, a current hot spot of gold production in the world markets. Orofino Gold Corp. is a Colombia based gold producer founded as a private company in 2009 by former executives with over 50 cumulative years in mining exploration, finance, and development expertise.<br />
<br />
<strong>Orofino Gold Corp. (ORFG)</strong> is pleased to announce the appointment of Dr. Hans Bocker as the new Chairman of the Board.<br />
The Company held a Board meeting dated April 5, 2011, to initiate certain corporate changes to the existing members of the Board of Directors. The Board of Directors unanimously appointed Dr. Hans Bocker as the new Chairman of the Board, and the former Chairman, Mr. Ning Shi Long, resigned as Chairman due to personal obligations, but will remain as a member of the Board of Directors.<br />
<br />
Dr. Hans J. Bocker is an internationally recognized academic advisor. His expertise encompasses fundamental organizational and operational logistics including production and operations management, purchasing and procurement, safety, loss control, quality management, international management, cross-cultural management, transportation and traffic logistics, and leadership training for executives.<br />
<br />
In addition to his logistical expertise, Dr. Bocker is also an internationally recognized gold expert. He recently published a book on gold titled Freedom Through Gold which has sold out in several languages. He is also a published journalist with over 2000 publications.<br />
<br />
On behalf of the Board of Directors, the Company wishes to extend their gratitude to Mr. Ning Shi Long for his commitment and efforts as past Chairman of the Board.<br />
<br />
For more information about Orofino Gold Corp. visit its website</font> <a href="www.orofinogoldcorp.com"><font color="black">orofinogoldcorp.com</font></a><br /></span></span></span></span></p>
<p align="center"> </p>
<p align="center"> </p>
<p align="center">**************************************************************</p>
<p align="center"><strong>THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!</strong></p>
<p><strong><font color="blue"><font color="red">Disclaimer:</font> Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (<font color="red">Read more at <a href="stock-pr.com/?page_id=40" target="_blank"><font color="red">stock-pr.com/disclaimer</font></a></font>).</font></strong><span style="COLOR: red"><span style="COLOR: red"><strong><font color="blue">Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. <font color="red">Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRME.OB). Crown Equity Holdings Inc. (OTCPK:CRWE) has previously received 500,000 shares of (144) restricted common stock and 500,000 shares of free trading shares from a third party (QU CUI You) for six months of advertisement services (which has expired) for Orofino Gold Corp. (PINK SHEETS:ORFG).</font></font></strong></span></span></p>
<p><span style="COLOR: red"><span style="COLOR: red"><strong><font color="blue"><font color="red"><br /></font><br /></font></strong></span></span></p>
<p align="center">Sign Up For Free Stock Alerts At <a href="stock-pr.com/signup" target="_blank">stock-pr.com/signup</a></p>
<p align="center"><a href="www.crownequityholdings.com" target="_blank"><img alt="stock-pr.com/img/stock-pr_buscard.jpg" src="stock-pr.com/img/stock-pr_buscard.jpg" /></a></p>
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.